|
Re: Today's trading...
|
6
|
Resverlogix Corp.
|
Sep 01, 2020 12:03PM
|
|
Re: Covid opportunity
|
6
|
Resverlogix Corp.
|
Mar 08, 2021 04:20PM
|
|
Re: Pfizer's patent application and a potential Priority Review Voucher?
|
6
|
Resverlogix Corp.
|
May 23, 2017 10:12AM
|
|
Re: I don’t get it
|
6
|
Resverlogix Corp.
|
May 23, 2019 03:08AM
|
|
Re: SP 52 week low
|
6
|
Resverlogix Corp.
|
Oct 05, 2022 04:40PM
|
|
Re: Rules of thumb and broken thumbs...
|
6
|
Resverlogix Corp.
|
Sep 30, 2020 02:48PM
|
|
Re: NEO Compensation
|
6
|
Resverlogix Corp.
|
May 22, 2021 04:55PM
|
|
Re: A Question for all here, the frustrated people, the P.O people, the content people & the koolaid people.....
|
6
|
Resverlogix Corp.
|
Jan 10, 2021 04:01PM
|
|
Re: RBC unregistered to registered account
|
6
|
Zenith Epigenetics
|
Apr 01, 2019 03:10AM
|
|
Re: Resverlogix Announces Participation at Prominent Industry and Investor Conferences
|
6
|
Resverlogix Corp.
|
Mar 11, 2019 10:54PM
|
|
Since we're speculating
|
6
|
Resverlogix Corp.
|
Jan 05, 2018 05:21PM
|
|
Re: Things are happening
|
6
|
Resverlogix Corp.
|
Aug 03, 2018 09:36PM
|
|
Failure of AZN's anifrolumab could be good for RVX
|
6
|
Resverlogix Corp.
|
Aug 31, 2018 03:57PM
|
|
Re: Celgene inks $1B deal for a preclinical epigenetic blood cancer drug from Canada.
|
6
|
Zenith Epigenetics
|
Feb 03, 2019 04:01AM
|
|
Re: Resverlogix Receives FDA Protocol Acceptance for the Ongoing Phase 3 BETonMACE Trial
|
6
|
Resverlogix Corp.
|
Jan 11, 2018 01:23PM
|
|
Re: ZEN-3694 Single Agent Trial Status
|
6
|
Zenith Epigenetics
|
Sep 18, 2017 11:17PM
|
|
Re: An ESC video from youtube that mentions Apabetalone, posted July 10 2019
|
6
|
Resverlogix Corp.
|
Sep 10, 2019 02:40PM
|
|
Re: No news
|
6
|
Resverlogix Corp.
|
Sep 16, 2022 04:29PM
|
|
Re: The MD@A for the period ending July 31, 2017
|
6
|
Resverlogix Corp.
|
Sep 19, 2017 12:26AM
|
|
Re: ORI Debenture
|
6
|
Resverlogix Corp.
|
Oct 04, 2019 02:21PM
|
